Steroid osteoporosis.
作者信息
Spector T D, Sambrook P N
出版信息
BMJ. 1993 Aug 28;307(6903):519-20. doi: 10.1136/bmj.307.6903.519.
Abstract
摘要
相似文献
1
Steroid osteoporosis.类固醇性骨质疏松症
BMJ. 1993 Aug 28;307(6903):519-20. doi: 10.1136/bmj.307.6903.519.
2
Steroid-induced osteoporosis.
Community Nurse. 1997 Jan;2(11):22-4.
3
Steroid side effects also seen in asthmatics ... but aerosol steroids reduce systemic risk.
JAMA. 1982 May 21;247(19):2657-8.
4
Corticosteroid therapy: a link to osteoporosis.
Orthop Nurs. 2000 Jul-Aug;19(4):79.
5
Steroid induced osteoporosis.类固醇诱导的骨质疏松症。
BMJ. 1992 Nov 28;305(6865):1362. doi: 10.1136/bmj.305.6865.1362.
6
Osteoporosis and long-term corticosteroid therapy.骨质疏松症与长期皮质类固醇治疗。
Br Med J. 1973 Sep 1;3(5878):498. doi: 10.1136/bmj.3.5878.498-b.
7
Corticoids in osteoporosis.
Ann Intern Med. 1971 Jun;74(6):1013-4. doi: 10.7326/0003-4819-74-6-1013.
8
[Prevalence of steroid osteoporosis].
Clin Calcium. 2006 Nov;16(11):1782-7.
9
[Corticoid osteoporosis].
Med Klin. 1972 Sep 8;67(36):1149-57.
10
[Management of complications of steroid therapy].
Nihon Rinsho. 1984 Nov;42(11):2516-9.
引用本文的文献
1
Weight gain during the first year of life in relation to maternal smoking and breast feeding in Norway.挪威婴儿出生后第一年的体重增加与母亲吸烟及母乳喂养的关系
J Epidemiol Community Health. 1997 Jun;51(3):261-5. doi: 10.1136/jech.51.3.261.
2
A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.一项关于鲑鱼降钙素预防糖皮质激素治疗的颞动脉炎和风湿性多肌痛患者骨质流失的随机对照试验。
Calcif Tissue Int. 1996 Feb;58(2):73-80. doi: 10.1007/BF02529727.
3
Danish data confirm low prevalence of HRT among women prescribed oral corticosteroids.
BMJ. 1996 Nov 16;313(7067):1264. doi: 10.1136/bmj.313.7067.1264.
4
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.社区中口服糖皮质激素的使用与继发性骨质疏松症的预防：一项横断面研究。
BMJ. 1996 Aug 10;313(7053):344-6. doi: 10.1136/bmj.313.7053.344.
5
Drug-induced disorders of bone metabolism. Incidence, management and avoidance.药物性骨代谢紊乱。发病率、管理与预防
Drug Saf. 1994 Jun;10(6):480-9. doi: 10.2165/00002018-199410060-00006.
6
Osteoporosis in rheumatological practice: questions to be answered.风湿病临床实践中的骨质疏松症：有待解答的问题
Ann Rheum Dis. 1995 Jan;54(1):1-2. doi: 10.1136/ard.54.1.1.
7
The risks and benefits of corticosteroids in advanced cancer.晚期癌症中使用皮质类固醇的风险与益处。
Drug Saf. 1994 Sep;11(3):163-78. doi: 10.2165/00002018-199411030-00003.
8
Polymyalgia rheumatica and giant cell arteritis. Consider prophylaxis for steroid induced osteoporosis.风湿性多肌痛和巨细胞动脉炎。考虑对类固醇诱导的骨质疏松症进行预防。
BMJ. 1995 Aug 12;311(7002):455-6. doi: 10.1136/bmj.311.7002.455c.
本文引用的文献
1
Risk of vertebral fracture in women with rheumatoid arthritis.类风湿关节炎女性患者椎体骨折的风险
BMJ. 1993 Feb 27;306(6877):558. doi: 10.1136/bmj.306.6877.558.
2
Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.皮质类固醇性骨质疏松症的预防。钙、骨化三醇和降钙素的比较。
N Engl J Med. 1993 Jun 17;328(24):1747-52. doi: 10.1056/NEJM199306173282404.
3
Steroid-induced fractures and bone loss in patients with asthma.哮喘患者的类固醇诱导性骨折和骨质流失
N Engl J Med. 1983 Aug 4;309(5):265-8. doi: 10.1056/NEJM198308043090502.
4
Fractures after rheumatoid arthritis. A population-based study.类风湿关节炎后的骨折。一项基于人群的研究。
Arthritis Rheum. 1984 Dec;27(12):1353-61. doi: 10.1002/art.1780271205.
5
Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.类风湿关节炎中的骨质疏松症：低剂量皮质类固醇的安全性
Ann Rheum Dis. 1986 Nov;45(11):950-3. doi: 10.1136/ard.45.11.950.
6
Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids.绝经后类风湿关节炎患者的椎骨和外周骨矿物质含量及骨折发生率：低剂量皮质类固醇的影响
Ann Rheum Dis. 1986 Oct;45(10):852-7. doi: 10.1136/ard.45.10.852.
7
Recovery from steroid-induced osteoporosis.
Ann Intern Med. 1987 Sep;107(3):319-23. doi: 10.7326/0003-4819-107-2-319.
8
Osteoporosis in patients with inflammatory bowel disease.炎症性肠病患者的骨质疏松症
Gut. 1987 Apr;28(4):410-5. doi: 10.1136/gut.28.4.410.
9
Glucocorticoid-induced osteoporosis.
Clin Rheum Dis. 1986 Dec;12(3):637-54.
10
Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).用（3-氨基-1-羟基亚丙基）-1,1-二膦酸酯（APD）预防类固醇诱导的骨质疏松症。
Lancet. 1988 Jan 23;1(8578):143-6. doi: 10.1016/s0140-6736(88)92721-3.
Zotero 插件